AU2013285078A1 - Saxagliptin salts - Google Patents

Saxagliptin salts Download PDF

Info

Publication number
AU2013285078A1
AU2013285078A1 AU2013285078A AU2013285078A AU2013285078A1 AU 2013285078 A1 AU2013285078 A1 AU 2013285078A1 AU 2013285078 A AU2013285078 A AU 2013285078A AU 2013285078 A AU2013285078 A AU 2013285078A AU 2013285078 A1 AU2013285078 A1 AU 2013285078A1
Authority
AU
Australia
Prior art keywords
saxagliptin
acetate
process according
bicarbonate
bisulphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013285078A
Other languages
English (en)
Inventor
Ram Chander Aryan
Ramendra Singh Rathore
Amit Sharma
Ashwani Kumar Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2013285078A1 publication Critical patent/AU2013285078A1/en
Assigned to SUN PHARMACEUTICAL INDUSTRIES LIMITED reassignment SUN PHARMACEUTICAL INDUSTRIES LIMITED Amend patent request/document other than specification (104) Assignors: RANBAXY LABORATORIES LIMITED
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2013285078A 2012-07-02 2013-07-02 Saxagliptin salts Abandoned AU2013285078A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN2061DE2012 2012-07-02
IN2061/DEL/2012 2012-07-02
IN3917DE2012 2012-12-19
IN3917/DEL/2012 2012-12-19
PCT/IB2013/055429 WO2014006569A2 (fr) 2012-07-02 2013-07-02 Sels de saxagliptine

Publications (1)

Publication Number Publication Date
AU2013285078A1 true AU2013285078A1 (en) 2015-01-29

Family

ID=54193750

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013285078A Abandoned AU2013285078A1 (en) 2012-07-02 2013-07-02 Saxagliptin salts

Country Status (5)

Country Link
EP (1) EP2867206A2 (fr)
AU (1) AU2013285078A1 (fr)
CA (1) CA2879824A1 (fr)
SG (1) SG11201408619WA (fr)
WO (1) WO2014006569A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2690321T3 (es) 2012-05-24 2018-11-20 Apotex Inc. Sales de saxagliptina con ácidos orgánicos
WO2015166466A1 (fr) * 2014-05-01 2015-11-05 Sun Pharmaceutical Industries Limited Forme cristalline d'acétate de saxagliptine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
US7420079B2 (en) 2002-12-09 2008-09-02 Bristol-Myers Squibb Company Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
TW200538122A (en) 2004-03-31 2005-12-01 Bristol Myers Squibb Co Process for preparing a dipeptidyl peptidase Ⅳ inhibitor and intermediates employed therein
US7741082B2 (en) 2004-04-14 2010-06-22 Bristol-Myers Squibb Company Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
US7214702B2 (en) 2004-05-25 2007-05-08 Bristol-Myers Squibb Company Process for producing a dipeptidyl peptidase IV inhibitor
PE20090696A1 (es) * 2007-04-20 2009-06-20 Bristol Myers Squibb Co Formas cristalinas de saxagliptina y procesos para preparar las mismas
US20120088808A1 (en) 2009-04-09 2012-04-12 Sandoz Ag Crystal forms of saxagliptin
EP2601175A1 (fr) 2010-08-06 2013-06-12 Sandoz AG Nouveau composé cristallin comprenant de la saxagliptine et de l'acide phosphorique
EP2601176A1 (fr) * 2010-08-06 2013-06-12 Sandoz AG Nouveaux sels de saxagliptine comportant des diacides organiques
WO2012047871A1 (fr) 2010-10-04 2012-04-12 Assia Chemical Industries Ltd Polymorphes de chlorhydrate de saxagliptine et leurs procédés de préparation
CN102086172A (zh) * 2011-01-13 2011-06-08 廖国超 沙格列汀的药用盐及其制备方法

Also Published As

Publication number Publication date
CA2879824A1 (fr) 2014-01-09
WO2014006569A2 (fr) 2014-01-09
SG11201408619WA (en) 2015-01-29
EP2867206A2 (fr) 2015-05-06
WO2014006569A3 (fr) 2014-03-06

Similar Documents

Publication Publication Date Title
WO2013179300A2 (fr) Procédé de préparation de vildagliptine et de son intermédiaire
WO2012025944A2 (fr) Sitagliptine, sels et polymorphes de celle-ci
TW201043619A (en) 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
JP7229997B2 (ja) Ｒｏｒガンマの阻害剤
TW202227397A (zh) 雙環的－雜環衍生物及相關用途
JP5635181B2 (ja) ニトロイミダゾール系化合物、その製造方法および用途
JP2021105003A (ja) 多形体及びキナゾリニル誘導体の調製プロセス
US10464906B2 (en) Crystalline forms of a histone deacetylase inhibitor
WO2018142327A1 (fr) Sels d'oxalate de ténéligliptine et solvates de ceux-ci, intermédiaires, procédé de préparation
AU2013285078A1 (en) Saxagliptin salts
EP2860180A1 (fr) Nouveaux sels gentisate d'inhibiteur de DPP-IV
US20150239909A1 (en) Process for the preparation of (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one
CA3150961A1 (fr) Procedes permettant la synthese de valbenazine
EP2896623A1 (fr) CRISTAL DE N-[2-({2-[(2S)-2-CYANOPYRROLIDIN-1-YL]-2- OXOÉTHYL}AMINO)-2-MÉTHYLPROPYL]-2-MÉTHYLPYRAZOLO[1,5-a]PYRIMIDINE-6-CARBOXAMIDE
WO2013084210A1 (fr) Forme amorphe de sels de sitagliptine
US20100298371A1 (en) Process for preparing chemically and chirally pure solifenacin base and its salts
AU2012277403A1 (en) Novel salts of sitagliptin
US20130123501A1 (en) Process for the preparation of the compound osi-906
US20150329489A1 (en) Saxagliptin salts
WO2014081024A1 (fr) Procédé de préparation de 2-phénylaminobenzamide substitué en 5ème position
US11434226B2 (en) Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereof
EP2797925B1 (fr) Procédé de préparation de (1r,4r)-6'-fluoro-(n,n-diméthyl- et n-méthyl)-4-phényl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol-4-amine
WO2015092624A1 (fr) Mono-oxalate de nilotinib et sa forme cristalline
WO2018163190A1 (fr) Procédé amélioré pour la préparation de varénicline et son sel
JP7430297B2 (ja) Ｎ－アルキルアミノ酸、およびｎ－アルキルアミノ酸を含むペプチドの製造方法

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted